FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000402512> ?p ?o ?g. }

• W2000402512 endingPage "543" @default.
• W2000402512 startingPage "536" @default.
• W2000402512 abstract "The enzyme β-secretase 1 (BACE-1) is associated with the catalytic cleavage of amyloid precursor protein (APP) which leads to the production of amyloid-β, an amyloidogenic peptide that forms insoluble fibrils and is linked to neurodegeneration and Alzheimer's disease (AD). A PET-radioligand for the quantification of BACE-1 would be useful for the understanding of AD. In this report, we describe the synthesis and carbon-11 radiolabeling of a potent hydroxyethylamine BACE-1 enzyme inhibitor (BSI-IV) and its evaluation in vitro and in vivo. 11[C]-N1-((2S,3R)-4-(cyclopropylamino)-3-hydroxy-1-phenylbutan-2-yl)-5-(N-methylmethyl-sulfonamido)-N3-((R)-1-phenylethyl)isophthalamide, a β-secretase inhibitor, denoted here as [11C]BSI-IV was synthesized through a palladium-mediated aminocarbonylation with an aryl halide precursor (I or Br) and [11C]CO. The effect of different palladium/ligand-complexes on radiochemical yield in the carbonylative reaction was investigated. The binding of the labeled compound to BACE-1 enzyme was studied in vitro by frozen section autoradiography from brains of healthy rats. Dynamic small animal PET-CT studies and ex vivo biodistribution were performed in male rats. The halide precursors were synthesized in six steps starting from methyl-3-nitrobenzoate with an overall yield of 21–26%. [11C]BSI-IV was obtained in 29 ± 12% decay corrected radiochemical yield (n = 12) with a specific activity of 790 ± 155 GBq/μmol at the end of synthesis with a radiochemical purity of > 99%. The preclinical studies showed that [11C]BSI-IV has a rapid metabolism in rat with excretion to the small intestines. 11[C]BSI-IV was obtained in sufficient amount and purity to enable preclinical investigation. The preclinical studies showed low specific binding in vitro and fast clearance in vivo and a low uptake in the brain. These findings suggests that [11C]BSI-IV has limited use as a PET-ligand for the study of BACE-1 or AD." @default.
• W2000402512 created "2016-06-24" @default.
• W2000402512 creator A5000559526 @default.
• W2000402512 creator A5008347976 @default.
• W2000402512 creator A5038912293 @default.
• W2000402512 creator A5061049141 @default.
• W2000402512 creator A5072386497 @default.
• W2000402512 date "2014-07-01" @default.
• W2000402512 modified "2023-09-24" @default.
• W2000402512 title "11C-Labeling of a potent hydroxyethylamine BACE-1 inhibitor and evaluation in vitro and in vivo" @default.
• W2000402512 cites W1586918204 @default.
• W2000402512 cites W1772512580 @default.
• W2000402512 cites W1960543132 @default.
• W2000402512 cites W1961730511 @default.
• W2000402512 cites W1965918817 @default.
• W2000402512 cites W1966734269 @default.
• W2000402512 cites W1967086954 @default.
• W2000402512 cites W1971117930 @default.
• W2000402512 cites W1974546112 @default.
• W2000402512 cites W1977169750 @default.
• W2000402512 cites W1989607398 @default.
• W2000402512 cites W1997858799 @default.
• W2000402512 cites W2001121359 @default.
• W2000402512 cites W2001402586 @default.
• W2000402512 cites W2002196872 @default.
• W2000402512 cites W2003059247 @default.
• W2000402512 cites W2016584130 @default.
• W2000402512 cites W2019646651 @default.
• W2000402512 cites W2023819682 @default.
• W2000402512 cites W2030473306 @default.
• W2000402512 cites W2032602280 @default.
• W2000402512 cites W2047186114 @default.
• W2000402512 cites W2048966170 @default.
• W2000402512 cites W2050373702 @default.
• W2000402512 cites W2069282965 @default.
• W2000402512 cites W2079749054 @default.
• W2000402512 cites W2090291844 @default.
• W2000402512 cites W2098735745 @default.
• W2000402512 cites W2104540241 @default.
• W2000402512 cites W2126415088 @default.
• W2000402512 cites W2129495914 @default.
• W2000402512 cites W2129771097 @default.
• W2000402512 cites W2136321913 @default.
• W2000402512 cites W2139983296 @default.
• W2000402512 cites W2151089477 @default.
• W2000402512 cites W2157750774 @default.
• W2000402512 cites W2160757053 @default.
• W2000402512 cites W2950098513 @default.
• W2000402512 cites W2969438869 @default.
• W2000402512 doi "https://doi.org/10.1016/j.nucmedbio.2014.03.024" @default.
• W2000402512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24857866" @default.
• W2000402512 hasPublicationYear "2014" @default.
• W2000402512 type Work @default.
• W2000402512 sameAs 2000402512 @default.
• W2000402512 citedByCount "17" @default.
• W2000402512 countsByYear W20004025122015 @default.
• W2000402512 countsByYear W20004025122016 @default.
• W2000402512 countsByYear W20004025122017 @default.
• W2000402512 countsByYear W20004025122018 @default.
• W2000402512 countsByYear W20004025122019 @default.
• W2000402512 countsByYear W20004025122020 @default.
• W2000402512 countsByYear W20004025122021 @default.
• W2000402512 countsByYear W20004025122022 @default.
• W2000402512 countsByYear W20004025122023 @default.
• W2000402512 crossrefType "journal-article" @default.
• W2000402512 hasAuthorship W2000402512A5000559526 @default.
• W2000402512 hasAuthorship W2000402512A5008347976 @default.
• W2000402512 hasAuthorship W2000402512A5038912293 @default.
• W2000402512 hasAuthorship W2000402512A5061049141 @default.
• W2000402512 hasAuthorship W2000402512A5072386497 @default.
• W2000402512 hasConcept C116569031 @default.
• W2000402512 hasConcept C142724271 @default.
• W2000402512 hasConcept C150903083 @default.
• W2000402512 hasConcept C170493617 @default.
• W2000402512 hasConcept C181199279 @default.
• W2000402512 hasConcept C185592680 @default.
• W2000402512 hasConcept C198684833 @default.
• W2000402512 hasConcept C202751555 @default.
• W2000402512 hasConcept C207001950 @default.
• W2000402512 hasConcept C2776970183 @default.
• W2000402512 hasConcept C2777807558 @default.
• W2000402512 hasConcept C2779134260 @default.
• W2000402512 hasConcept C2779281246 @default.
• W2000402512 hasConcept C31705614 @default.
• W2000402512 hasConcept C502032728 @default.
• W2000402512 hasConcept C55493867 @default.
• W2000402512 hasConcept C67847695 @default.
• W2000402512 hasConcept C71240020 @default.
• W2000402512 hasConcept C71924100 @default.
• W2000402512 hasConcept C86803240 @default.
• W2000402512 hasConceptScore W2000402512C116569031 @default.
• W2000402512 hasConceptScore W2000402512C142724271 @default.
• W2000402512 hasConceptScore W2000402512C150903083 @default.
• W2000402512 hasConceptScore W2000402512C170493617 @default.
• W2000402512 hasConceptScore W2000402512C181199279 @default.
• W2000402512 hasConceptScore W2000402512C185592680 @default.
• W2000402512 hasConceptScore W2000402512C198684833 @default.
• W2000402512 hasConceptScore W2000402512C202751555 @default.

• next